Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment

Anuj A. Shukla; Shreya Podder; Sana R. Chaudry; Bryan S. Benn; Jonathan S. Kurman; Anuj A. Shukla; Shreya Podder; Sana R. Chaudry; Bryan S. Benn; Jonathan S. Kurman

doi:10.3934/medsci.2022016

AIMS Medical Science

2022, Volume 9, Issue 2: 348-361. doi: 10.3934/medsci.2022016

Previous Article Next Article

Review Topical Sections

Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment

Division of Pulmonary & Critical Care, Medical College of Wisconsin, Milwaukee, WI, USA

Received: 16 January 2022 Revised: 20 May 2022 Accepted: 22 May 2022 Published: 26 May 2022

Lung cancer is the most common cancer worldwide and is also one of the leading causes of cancer related deaths. The 5-year survival rate depends largely on stage at diagnosis. Multiple large randomized controlled trials have demonstrated the clinical utility of lung cancer screening. Low dose computed tomography is recommended for lung cancer screening in several guidelines. Lung cancer is often diagnosed at more advanced stages owing to the nonspecific symptoms with which it presents. Diagnosis relies primarily upon imaging and biopsy. Diagnosis and staging should be performed simultaneously, if possible, by performing a biopsy at the site that will confer the highest stage. Sufficient material should be obtained to allow for molecular testing. Liquid biopsy may have a complementary role in detecting actionable mutations in non-small cell lung cancer. Treatment is predicated upon stage and may involve surgery, targeted chemotherapy, radiation therapy, immunotherapy, or some combination thereof.

Keywords:

Citation: Anuj A. Shukla, Shreya Podder, Sana R. Chaudry, Bryan S. Benn, Jonathan S. Kurman. Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment[J]. AIMS Medical Science, 2022, 9(2): 348-361. doi: 10.3934/medsci.2022016

Related Papers:

[1]	Miguel Vivas-Cortez, Muhammad Aamir Ali, Artion Kashuri, Hüseyin Budak . Generalizations of fractional Hermite-Hadamard-Mercer like inequalities for convex functions. AIMS Mathematics, 2021, 6(9): 9397-9421. doi: 10.3934/math.2021546
[2]	Saad Ihsan Butt, Artion Kashuri, Muhammad Umar, Adnan Aslam, Wei Gao . Hermite-Jensen-Mercer type inequalities via Ψ-Riemann-Liouville k-fractional integrals. AIMS Mathematics, 2020, 5(5): 5193-5220. doi: 10.3934/math.2020334
[3]	Miguel Vivas-Cortez, Muhammad Uzair Awan, Muhammad Zakria Javed, Artion Kashuri, Muhammad Aslam Noor, Khalida Inayat Noor . Some new generalized $\kappa$ –fractional Hermite–Hadamard–Mercer type integral inequalities and their applications. AIMS Mathematics, 2022, 7(2): 3203-3220. doi: 10.3934/math.2022177
[4]	Jia-Bao Liu, Saad Ihsan Butt, Jamshed Nasir, Adnan Aslam, Asfand Fahad, Jarunee Soontharanon . Jensen-Mercer variant of Hermite-Hadamard type inequalities via Atangana-Baleanu fractional operator. AIMS Mathematics, 2022, 7(2): 2123-2141. doi: 10.3934/math.2022121
[5]	Yanping Yang, Muhammad Shoaib Saleem, Waqas Nazeer, Ahsan Fareed Shah . New Hermite-Hadamard inequalities in fuzzy-interval fractional calculus via exponentially convex fuzzy interval-valued function. AIMS Mathematics, 2021, 6(11): 12260-12278. doi: 10.3934/math.2021710
[6]	Yamin Sayyari, Mana Donganont, Mehdi Dehghanian, Morteza Afshar Jahanshahi . Strongly convex functions and extensions of related inequalities with applications to entropy. AIMS Mathematics, 2024, 9(5): 10997-11006. doi: 10.3934/math.2024538
[7]	Jamshed Nasir, Saber Mansour, Shahid Qaisar, Hassen Aydi . Some variants on Mercer's Hermite-Hadamard like inclusions of interval-valued functions for strong Kernel. AIMS Mathematics, 2023, 8(5): 10001-10020. doi: 10.3934/math.2023506
[8]	Tahir Ullah Khan, Muhammad Adil Khan . Hermite-Hadamard inequality for new generalized conformable fractional operators. AIMS Mathematics, 2021, 6(1): 23-38. doi: 10.3934/math.2021002
[9]	Shahid Mubeen, Rana Safdar Ali, Iqra Nayab, Gauhar Rahman, Kottakkaran Sooppy Nisar, Dumitru Baleanu . Some generalized fractional integral inequalities with nonsingular function as a kernel. AIMS Mathematics, 2021, 6(4): 3352-3377. doi: 10.3934/math.2021201
[10]	Paul Bosch, Héctor J. Carmenate, José M. Rodríguez, José M. Sigarreta . Generalized inequalities involving fractional operators of the Riemann-Liouville type. AIMS Mathematics, 2022, 7(1): 1470-1485. doi: 10.3934/math.2022087

Abstract

Abbreviations

CISNET:

Cancer intervention and surveillance modeling network;

CT:

Computed tomography;

ctDNA:

Circulating tumor DNA;

EBUS:

Endobronchial ultrasound;

EBUS-NA:

Endobronchial ultrasound-guided needle aspiration;

EGFR:

Epidermal growth factor receptor;

ESTS:

European Society of Thoracic Surgeons;

EUS-NA:

Endoscopic ultrasound-guided needle aspiration;

IASLC:

International Association for the Study of Lung Cancer;

LDCT:

Low-dose computed tomography;

NCCN:

National Comprehensive Cancer Network;

NELSON:

Dutch-Belgian Randomized Lung Cancer Screening trial;

NILE:

Non-invasive versus invasive evaluation;

NLST:

National Lung Cancer Screen Trial;

NSCLC:

Non-small cell lung cancer;

PD-L1:

Programmed cell death ligand;

PET:

Positron emission tomography;

RCTs:

Randomized controlled trials;

RT:

Radiation therapy;

SEER:

Surveillance, Epidemiology and End Results;

TBNA:

Transbronchial needle aspiration;

TKI:

Tyrosine kinase inhibitor;

TNM:

Tumor-node-metastasis;

USPTF:

United States Preventative Service Task Force;

WHO:

World Health Organization

1. Introduction

For a convex function $\sigma:\mathrm{I}\subseteq \bf{R}\to \bf{R}$ on $\mathrm{I}$ with $\nu_{1}, \nu_{2}\in \mathrm{I}$ and $\nu_{1} < \nu_{2}$ , the Hermite-Hadamard inequality is defined by ^[1]:

$\begin{equation} \sigma\left(\frac{\nu_{1}+\nu_{2}}{2}\right) \leq \frac{1}{\nu_{2}-\nu_{1}}\int_{\nu_{1}}^{\nu_{2}}\sigma(\eta)d\eta \leq \frac{\sigma(\nu_{1})+\sigma(\nu_{2})}{2}. \end{equation}$

(1.1)

The Hermite-Hadamard integral inequality (1.1) is one of the most famous and commonly used inequalities. The recently published papers ^[2,3,4] are focused on extending and generalizing the convexity and Hermite-Hadamard inequality.

The situation of the fractional calculus (integrals and derivatives) has won vast popularity and significance throughout the previous five decades or so, due generally to its demonstrated applications in numerous seemingly numerous and great fields of science and engineering ^[5,6,7].

Now, we recall the definitions of Riemann-Liouville fractional integrals.

Definition 1.1 (^[5,6,7]). Let $\sigma\in L_{1}[\nu_{1}, \nu_{2}].$ The Riemann-Liouville integrals $J_{\nu_{1}+}^{\vartheta }\sigma$ and $J_{\nu_{2}-}^{\vartheta }\sigma$ of order $\vartheta > 0$ with $\nu_{1}\geq 0$ are defined by

$\begin{equation} J_{\nu_{1}+}^{\vartheta }\sigma(x) = \frac{1}{\Gamma (\vartheta )}\int_{\nu_{1}}^{x}(x-\eta)^{\vartheta -1}\sigma(\eta)d\eta,\; \ \ \ \nu_{1} < x \end{equation}$

(1.2)

and

$\begin{equation} J_{\nu_{2}-}^{\vartheta }\sigma(x) = \frac{1}{\Gamma (\vartheta )}\int_{x}^{\nu_{2}}(\eta-x)^{\vartheta -1}\sigma(\eta)d\eta,\; \ \ x < \nu_{2}, \end{equation}$

(1.3)

respectively. Here $\Gamma (\vartheta)$ is the well-known Gamma function and $J_{\nu_{1}+}^{0}\sigma(x) = J_{\nu_{2}-}^{0}\sigma(x) = \sigma(x).$

With a huge application of fractional integration and Hermite-Hadamard inequality, many researchers in the field of fractional calculus extended their research to the Hermite-Hadamard inequality, including fractional integration rather than ordinary integration; for example see ^{[8,9,10,11,12,13,14,15,16,17,18,19,20,21]}.

In this paper, we consider the integral inequality of Hermite-Hadamard-Mercer type that relies on the Hermite-Hadamard and Jensen-Mercer inequalities. For this purpose, we recall the Jensen-Mercer inequality: Let $0 < x_{1}\leq x_{2}\leq \cdots\leq x_{n}$ and $\mu = (\mu _{1}, \mu_{2}, \ldots, \mu _{n})$ nonnegative weights such that $\sum_{i = 1}^{n}\mu_{i} = 1$ . Then, the Jensen inequality ^[22,23] is as follows, for a convex function $\sigma$ on the interval $[\nu_{1}, \nu_{2}]$ , we have

$\begin{equation} \sigma\Bigg(\sum\limits_{i = 1}^{n}\mu _{i}x_{i}\Bigg)\leq \sum\limits_{i = 1}^{n}\mu _{i}\sigma(x_{i}), \end{equation}$

(1.4)

where for all $x_{i}\in \lbrack \nu_{1}, \nu_{2}]$ and $\mu_{i}\in \lbrack 0, 1]$ , $(i = \overline{1, n})$ .

Theorem 1.1 (^[2,23]). If $\sigma$ is convex function on $[\nu_{1}, \nu_{2}]$ , then

$\begin{equation} \sigma\left(\nu_{1}+\nu_{2}-\sum\limits^{n}_{i = 1}\mu_{i}x_{i}\right)\leq \sigma(\nu_{1})+\sigma(\nu_{2})-\sum\limits^{n}_{i = 1}\mu_{i}\sigma(x_{i}), \end{equation}$

(1.5)

for each $x_{i}\in[\nu_{1}, \nu_{2}]$ and $\mu_{i}\in[0, 1]$ , $(i = \overline{1, n})$ with $\sum^{n}_{i = 1}\mu_{i} = 1$ . For some results related with Jensen-Mercer inequality, see ^[24,25,26].

In view of above indices, we establish new integral inequalities of Hermite-Hadamard-Mercer type for convex functions via the Riemann-Liouville fractional integrals in the current project. Particularly, we see that our results can cover the previous researches.

2. Main results

Theorem 2.1. For a convex function $\sigma:[\nu_{1}, \nu_{2}]\subseteq \bf{R} \to\bf{R}$ with $x, y\in[\nu_{1}, \nu_{2}]$ , we have:

$\begin{multline} \sigma\left(\nu_{1}+\nu_{2}-\frac{x+y}{2}\right)\leq \frac{2^{\vartheta -1} \Gamma\left(\vartheta +1\right)}{\left( y-x\right)^{\vartheta}} \Biggl[ J_{\left(\nu_{1}+\nu_{2}-y\right)+}^{\vartheta}\sigma\left(\nu_{1}+\nu_{2}-\frac{x+y}{2}\right) \\ +\; J_{\left(\nu_{1}+\nu_{2}-x\right)-}^{\vartheta}\sigma\left(\nu_{1}+\nu_{2}-\frac{x+y}{2}\right)\Biggr] \leq \sigma\left(\nu_{1}\right)+\sigma\left(\nu_{2}\right)-\frac{\sigma\left(x\right)+\sigma\left(y\right)}{2}. \end{multline}$

(2.1)

Proof. By using the convexity of $\sigma$ , we have

$\begin{equation} \sigma\left( \nu_{1}+\nu_{2}-\frac{u+v}{2}\right) \leq \frac{1}{2}\left[ \sigma\left( \nu_{1}+\nu_{2}-u\right) +\sigma\left( \nu_{1}+\nu_{2}-v\right) \right], \end{equation}$

(2.2)

and above with $u = \frac{1-\eta}{2}x+\frac{1+\eta}{2}y$ , $v = \frac{1+\eta}{2}x+\frac{1-\eta}{2}y$ , where $x, y\in[\nu_{1}, \nu_{2}]$ and $\eta\in [0, 1]$ , leads to

$\begin{multline} \sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right)\leq\frac{1}{2} \Biggl[\sigma\left(\nu_{1}+\nu_{2}-\left(\frac{1-\eta}{2}x+\frac{1+\eta}{2}y\right)\right) \\ +\sigma\left(\nu_{1}+\nu_{2}-\left(\frac{1+\eta}{2}x+\frac{1-\eta}{2}y\right)\right)\Biggr]. \end{multline}$

(2.3)

Multiplying both sides of (2.3) by $\eta^{\vartheta -1}$ and then integrating with respect to $\eta$ over $[0, 1]$ , we get

$\begin{align*} \frac{1}{\vartheta }\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right) &\leq \frac{1}{2}\left[\int_{0}^{1}\eta^{\vartheta-1} \sigma\left(\nu_{1}+\nu_{2}-\left(\frac{1-\eta}{2}x+\frac{1+\eta}{2}y\right)\right)d\eta\right. \\ &+\left. \int_{0}^{1}\eta^{\vartheta -1}\sigma\left( \nu_{1}+\nu_{2}-\left( \frac{1+\eta}{2}x+\frac{1-\eta}{2}y\right)\right)d\eta\right] \\ & = \frac{1}{2}\left[ \frac{2^{\vartheta }}{\left( y-x\right) ^{\vartheta }}\int_{\nu_{1}+\nu_{2}-y}^{\nu_{1}+\nu_{2}-\frac{x+y}{2}} \left( \left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right)-w\right) ^{\vartheta -1}\sigma\left( w\right) dw\right. \\ &\left. +\frac{2^{\vartheta}}{\left(y-x\right)^{\vartheta}}\int_{\nu_{1}+\nu_{2}-\frac{x+y}{2}}^{\nu_{1}+\nu_{2}-x} \left( w-\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right) \right) ^{\vartheta-1}\sigma\left( w\right) dw\right] \\ & = \frac{2^{\vartheta-1}\Gamma \left(\vartheta\right)}{\left(y-x\right)^{\vartheta}} \left[J_{\left(\nu_{1}+\nu_{2}-y\right)+}^{\vartheta}\sigma\left(\nu_{1}+\nu_{2}-\frac{x+y}{2}\right) +\; J_{\left(\nu_{1}+\nu_{2}-x\right)-}^{\vartheta}\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right) \right], \end{align*}$

and thus the proof of first inequality in (2.1) is completed.

On the other hand, we have by using the Jensen-Mercer inequality:

$\begin{eqnarray} \sigma\left( \nu_{1}+\nu_{2}-\left( \frac{1-\eta}{2}x+\frac{1+\eta}{2}y\right) \right) &\leq &\sigma\left( \nu_{1}\right) +\sigma\left( \nu_{2}\right) -\left( \frac{1-\eta}{2}\sigma\left( x\right) +\frac{1+\eta}{2}\sigma\left( y\right) \right) \end{eqnarray}$

(2.4)

$\begin{eqnarray} \sigma\left( \nu_{1}+\nu_{2}-\left( \frac{1+\eta}{2}x+\frac{1-\eta}{2}y\right) \right) &\leq &\sigma\left( \nu_{1}\right) +\sigma\left( \nu_{2}\right) -\left( \frac{1+\eta}{2}\sigma\left( x\right) +\frac{1-\eta}{2}\sigma\left( y\right) \right). \end{eqnarray}$

(2.5)

Adding inequalities (2.4) and (2.5) to get

$\begin{multline} \sigma\left( \nu_{1}+\nu_{2}-\left( \frac{1-\eta}{2}x+\frac{1+\eta}{2}y\right) \right) +\sigma\left(\nu_{1}+\nu_{2}-\left( \frac{1+\eta}{2}x+\frac{1-\eta}{2}y\right) \right) \\ \leq 2\left[\sigma\left(\nu_{1}\right)+\sigma\left(\nu_{2}\right)\right]-\left[\sigma\left(x\right)+\sigma\left(y\right)\right]. \end{multline}$

(2.6)

Multiplying both sides of (2.6) by $\eta^{\vartheta -1}$ and then integrating with respect to $\eta$ over $[0, 1]$ to obtain

$\begin{multline*} \int_{0}^{1}\eta^{\vartheta -1}\sigma\left( \nu_{1}+\nu_{2}-\left( \frac{1-\eta}{2}x+\frac{1+\eta}{2}y\right) \right)d\eta +\int_{0}^{1}\eta^{\vartheta-1}\sigma\left(\nu_{1}+\nu_{2}-\left(\frac{1+\eta}{2}x+\frac{1-\eta}{2}y\right)\right)d\eta \\ \leq \frac{2}{\vartheta}\left[\sigma\left(\nu_{1}\right)+\sigma\left(\nu_{2}\right)\right] -\frac{1}{\vartheta }\left[ \sigma\left( x\right) +\sigma\left( y\right) \right]. \end{multline*}$

By making use of change of variables and then multiplying by $\frac{\vartheta }{2}$ , we get the second inequality in (2.1).

Remark 2.1. If we choose $\vartheta = 1$ , $x = \nu_{1}$ and $y = \nu_{2}$ in Theorem 2.1, then the inequality (2.1) reduces to (1.1).

Corollary 2.1. Theorem 2.1 with

● $\vartheta = 1$ becomes [24, Theorem 2.1].

● $x = \nu_{1}$ and $y = \nu_{2}$ becomes:

$\begin{align*} \sigma\left(\frac{\nu_{1}+\nu_{2}}{2}\right)\leq\frac{2^{\vartheta-1}\Gamma\left(\vartheta+1\right)}{\left(\nu_{2}-\nu_{1}\right)^{\vartheta}} \left[J_{\nu_{1}+}^{\vartheta }\sigma\left(\frac{\nu_{1}+\nu_{2}}{2}\right)+\; J_{\nu_{2}-}^{\vartheta }\sigma\left(\frac{\nu_{1}+\nu_{2}}{2}\right)\right] \leq \frac{\sigma\left(\nu_{1}\right)+\sigma\left(\nu_{2}\right) }{2}, \end{align*}$

which is obtained by Mohammed and Brevik in ^[10].

The following Lemma linked with the left inequality of (2.1) is useful to obtain our next results.

Lemma 2.1. Let $\sigma:[\nu_{1}, \nu_{2}]\subseteq\bf{R} \to\bf{R}$ be a differentiable function on $(\nu_{1}, \nu_{2})$ and $\sigma'\in L[\nu_{1}, \nu_{2}]$ with $\nu_{1}\leq \nu_{2}$ and $x, y\in[\nu_{1}, \nu_{2}]$ . Then, we have:

$\begin{multline} \frac{2^{\vartheta -1}\Gamma \left( \vartheta +1\right) }{\left( y-x\right)^{\vartheta}} \left[ J_{\left( \nu_{1}+\nu_{2}-y\right) +}^{\vartheta }\sigma\left(\nu_{1}+\nu_{2}-\frac{x+y}{2}\right) +\; J_{\left( \nu_{1}+\nu_{2}-x\right)-}^{\vartheta}\sigma\left(\nu_{1}+\nu_{2}-\frac{x+y}{2}\right)\right] \\ -\sigma\left(\nu_{1}+\nu_{2}-\frac{x+y}{2}\right) = \frac{\left(y-x\right)}{4}\int_{0}^{1}\eta^{\vartheta} \Bigl[\sigma'\left(\nu_{1}+\nu_{2}-\left(\frac{1-\eta}{2}x+\frac{1+\eta}{2}y\right)\right) \\ -\sigma'\left(\nu_{1}+\nu_{2}-\left(\frac{1+\eta}{2}x+\frac{1-\eta}{2}y\right)\right)\Bigr]d\eta. \end{multline}$

(2.7)

Proof. From right hand side of (2.7), we set

$\begin{align} \varpi_{1}-\varpi_{2}&:= \int_{0}^{1}\eta^{\vartheta}\left[\sigma'\left(\nu_{1}+\nu_{2} -\left(\frac{1-\eta}{2}x+\frac{1+\eta}{2}y\right)\right) -\sigma'\left( \nu_{1}+\nu_{2}-\left( \frac{1+\eta}{2}x+\frac{1-\eta}{2}y\right)\right)\right]d\eta \\ & = \int_{0}^{1}\eta^{\vartheta }\sigma'\left(\nu_{1}+\nu_{2}-\left(\frac{1-\eta}{2}x+\frac{1+\eta}{2}y\right)\right)d\eta \\ &-\int_{0}^{1}\eta^{\vartheta}\sigma'\left(\nu_{1}+\nu_{2}-\left(\frac{1+\eta}{2}x+\frac{1-\eta}{2}y\right)\right) d\eta. \end{align}$

(2.8)

By integrating by parts with $w = \nu_{1}+\nu_{2}-\left(\frac{1-\eta}{2}x+\frac{1+\eta}{2}y\right)$ , we can deduce:

$\begin{align*} \varpi_{1}& = -\frac{2}{\left( y-x\right) }\sigma\left(\nu_{1}+\nu_{2}-y\right)+\frac{2\vartheta }{\left(y-x\right)} \int_{0}^{1}\eta^{\vartheta -1}\sigma\left( \nu_{1}+\nu_{2}-\left( \frac{1-\eta}{2}x+\frac{1+\eta}{2}y\right) \right) d\eta \\ & = -\frac{2}{\left(y-x\right)}\sigma\left(\nu_{1}+\nu_{2}-y\right)+\frac{2^{\vartheta+1}\vartheta}{\left(y-x\right)^{\vartheta+1}} \int_{\nu_{1}+\nu_{2}-y}^{\nu_{1}+\nu_{2}-\frac{x+y}{2}}\sigma\left(\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right)-w\right)^{\vartheta -1} \sigma\left(w\right) dw \\ & = -\frac{2}{\left(y-x\right)}\sigma\left( \nu_{1}+\nu_{2}-y\right) +\frac{2^{\vartheta+1}\Gamma\left(\vartheta+1\right)}{\left( y-x\right) ^{\vartheta +1}} J_{\left(\nu_{1}+\nu_{2}-y\right)+}^{\vartheta }\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right). \end{align*}$

Similarly, we can deduce:

$\begin{equation*} \varpi_{2} = \frac{2}{y-x}\sigma\left(\nu_{1}+\nu_{2}-x\right) -\frac{2^{\vartheta+1}\Gamma\left(\vartheta+1\right)}{\left( y-x\right) ^{\vartheta +1}} J_{\left( \nu_{1}+\nu_{2}-x\right)-}^{\vartheta }\sigma\left(\nu_{1}+\nu_{2}-\frac{x+y}{2}\right). \end{equation*}$

By substituting $\varpi_{1}$ and $\varpi_{2}$ in (2.8) and then multiplying by $\frac{\left(y-x\right)}{4}$ , we obtain required identity (2.7).

Corollary 2.2. Lemma 2.1 with

● $\vartheta = 1$ becomes:

$\begin{multline*} \frac{1}{y-x}\int_{\nu_{1}+\nu_{2}-y}^{\nu_{1}+\nu_{2}-x}\sigma\left(w\right) dw-\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right) = \frac{\left( y-x\right) }{4}\int_{0}^{1}\eta\left[ \sigma'\left( \nu_{1}+\nu_{2}-\left( \frac{1-\eta}{2}x+\frac{1+\eta}{2}y\right) \right) \right. \\ \left. -\sigma'\left( \nu_{1}+\nu_{2}-\left( \frac{1+\eta}{2}x+\frac{1-\eta}{2}y\right)\right) \right] d\eta. \end{multline*}$

● $\vartheta = 1$ , $x = \nu_{1}$ and $y = \nu_{2}$ becomes:

$\begin{multline*} \frac{1}{\nu_{2}-\nu_{1}}\int_{\nu_{1}}^{\nu_{2}}\sigma\left( w\right) dw-\sigma\left(\frac{\nu_{1}+\nu_{2}}{2}\right) = \frac{\left( \nu_{2}-\nu_{1}\right) }{4}\int_{0}^{1}\eta \left[ \sigma'\left(\nu_{1}+\nu_{2}-\left( \frac{1-\eta}{2}\nu_{1}+\frac{1+\eta}{2}\nu_{2}\right) \right) \right. \\ \left. -\sigma'\left( \nu_{1}+\nu_{2}-\left( \frac{1+\eta}{2}\nu_{1}+\frac{1-\eta}{2}\nu_{2}\right)\right) \right] d\eta. \end{multline*}$

● $x = \nu_{1}$ and $y = \nu_{2}$ becomes:

$\begin{multline*} \frac{2^{\vartheta -1}\Gamma \left( \vartheta +1\right) }{\left( \nu_{2}-\nu_{1}\right)^{\vartheta }} \left[ J_{\nu_{1}+}^{\vartheta }\sigma\left(\frac{\nu_{1}+\nu_{2}}{2}\right) +\; J_{\nu_{2}-}^{\vartheta }\sigma\left(\frac{\nu_{1}+\nu_{2}}{2}\right) \right]-\sigma\left(\frac{\nu_{1}+\nu_{2}}{2}\right) \\ = \frac{\left( \nu_{2}-\nu_{1}\right) }{4}\int_{0}^{1}\eta^{\vartheta } \left[\sigma'\left( \nu_{1}+\nu_{2}-\left( \frac{1-\eta}{2}\nu_{1}+\frac{1+\eta}{2}\nu_{2}\right) \right) \right. \left. -\sigma'\left( \nu_{1}+\nu_{2}-\left( \frac{1+\eta}{2}\nu_{1}+\frac{1-\eta}{2}\nu_{2}\right) \right) \right] d\eta. \end{multline*}$

Theorem 2.2. Let $\sigma:[\nu_{1}, \nu_{2}]\subseteq\bf{R}\to\bf{R}$ be a differentiable function on $(\nu_{1}, \nu_{2})$ and $|\sigma'|$ is convex on $[\nu_{1}, \nu_{2}]$ with $\nu_{1}\leq \nu_{2}$ and $x, y\in[\nu_{1}, \nu_{2}]$ . Then, we have:

$\begin{multline} \Biggl| \frac{2^{\vartheta -1}\Gamma \left( \vartheta +1\right) }{\left(y-x\right) ^{\vartheta }} \Biggl[ J_{\left( \nu_{1}+\nu_{2}-y\right) +}^{\vartheta }\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right) +\; J_{\left( \nu_{1}+\nu_{2}-x\right) -}^{\vartheta }\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right) \Biggr] \\ -\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right)\Biggr| \leq \frac{\left( y-x\right) }{2\left( 1+\vartheta \right) }\left[ \left| \sigma'\left( \nu_{1}\right) \right| +\left| \sigma'\left(\nu_{2}\right) \right| -\frac{\left| \sigma'\left( x\right) \right| +\left| \sigma'\left( y\right) \right| }{2}\right]. \end{multline}$

(2.9)

Proof. By taking modulus of identity (2.7), we get

$\begin{multline*} \Biggl|\frac{2^{\vartheta-1}\Gamma\left(\vartheta+1\right)}{\left(y-x\right)^{\vartheta}} \left[J_{\left(\nu_{1}+\nu_{2}-y\right)+}^{\vartheta}\sigma\left(\nu_{1}+\nu_{2}-\frac{x+y}{2}\right) +\; J_{\left( \nu_{1}+\nu_{2}-x\right) -}^{\vartheta }\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right) \right] \\ -\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right) \Biggr|\leq \frac{\left( y-x\right) }{4} \left[\int_{0}^{1}\eta^{\vartheta }\left|\sigma'\left( \nu_{1}+\nu_{2}-\left( \frac{1-\eta}{2}x+\frac{1+\eta}{2}y\right) \right) \right| d\eta\right. \\ \left. +\int_{0}^{1}\eta^{\vartheta }\left| \sigma'\left( \nu_{1}+\nu_{2}-\left( \frac{1+\eta}{2}x+\frac{1-\eta}{2}y\right) \right) \right| d\eta\right]. \end{multline*}$

Then, by applying the convexity of $|\sigma'|$ and the Jensen-Mercer inequality on above inequality, we get

$\begin{align*} &\Biggl|\frac{2^{\vartheta-1}\Gamma\left(\vartheta+1\right)}{\left(y-x\right)^{\vartheta}} \left[J_{\left(\nu_{1}+\nu_{2}-y\right)+}^{\vartheta}\sigma\left(\nu_{1}+\nu_{2}-\frac{x+y}{2}\right) +\; J_{\left( \nu_{1}+\nu_{2}-x\right) -}^{\vartheta }\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right) \right] \\ &-\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right) \Biggr|\leq \frac{\left( y-x\right) }{4}\left[ \int_{0}^{1}\eta^{\vartheta }\left[ \left| \sigma'\left( \nu_{1}\right) \right| +\left| \sigma'\left( \nu_{2}\right) \right| -\left( \frac{1+\eta}{2}\left| \sigma^{\prime }\left( x\right) \right| +\frac{1-\eta}{2}\right) \left| \sigma'\left( y\right) \right| \right] d\eta\right. \\ &\left. +\int_{0}^{1}\eta^{\vartheta }\left[ \left| \sigma'\left(\nu_{1}\right) \right| +\left| \sigma'\left( \nu_{2}\right) \right| -\left(\frac{1-\eta}{2}\left|\sigma'\left(x\right) \right| +\frac{1+\eta}{2}\right)\left| \sigma'\left( y\right)\right| \right] d\eta\right] \\ & = \frac{\left(y-x\right)}{2\left(1+\vartheta \right)}\left[ \left|\sigma'\left( \nu_{1}\right)\right| +\left|\sigma'(\nu_{2})\right|-\frac{\left|\sigma'\left(x\right)\right|+\left|\sigma'\left(y\right)\right|}{2}\right], \end{align*}$

which completes the proof of Theorem 2.2.

Corollary 2.3. Theorem 2.2 with

● $\vartheta = 1$ becomes:

$\begin{align*} \left|\frac{1}{y-x}\int_{\nu_{1}+\nu_{2}-y}^{\nu_{1}+\nu_{2}-x}\sigma(w)dw-\sigma\left(\nu_{1}+\nu_{2}-\frac{x+y}{2}\right)\right| \leq \frac{\left(y-x\right)}{4}\left[\left| \sigma'\left(\nu_{1}\right)\right|+\left|\sigma'\left(\nu_{2}\right)\right| -\frac{\left|\sigma'\left(x\right)\right|+\left|\sigma'\left(y\right)\right|}{2}\right]. \end{align*}$

● $\vartheta = 1$ , $x = \nu_{1}$ and $y = \nu_{2}$ becomes [27, Theorem 2.2].

● $x = \nu_{1}$ and $y = \nu_{2}$ becomes:

$\begin{align*} \left\vert \frac{1}{\nu_{2}-\nu_{1}}\int_{\nu_{1}}^{\nu_{2}}\sigma\left( w\right) dw-\sigma\left(\frac{\nu_{1}+\nu_{2}}{2}\right) \right\vert \leq \frac{\left( \nu_{2}-\nu_{1}\right) }{4}\left[ \frac{\left\vert \sigma^{\prime }\left( \nu_{1}\right) \right\vert +\left\vert \sigma^{\prime }\left( \nu_{2}\right) \right\vert }{2}\right] . \end{align*}$

Theorem 2.3. Let $\sigma:[\nu_{1}, \nu_{2}]\subseteq\bf{R}\to\bf{R}$ be a differentiable function on $(\nu_{1}, \nu_{2})$ and $\left| \sigma'\right|^{q}, q > 1$ is convex on $[\nu_{1}, \nu_{2}]$ with $\nu_{1}\leq \nu_{2}$ and $x, y\in[\nu_{1}, \nu_{2}]$ . Then, we have:

$\begin{multline} \left| \frac{2^{\vartheta -1}\Gamma \left( \vartheta +1\right) }{\left( y-x\right) ^{\vartheta }}\left[ J_{\left( \nu_{1}+\nu_{2}-y\right) +}^{\vartheta }\sigma\left( \nu_{1}+\nu_{2}- \frac{x+y}{2}\right) \right. \right. \\ \left. \left. +\; J_{\left( \nu_{1}+\nu_{2}-x\right) -}^{\vartheta }\sigma\left(\nu_{1}+\nu_{2}-\frac{x+y}{2}\right) \right] -\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right) \right| \\ \leq \frac{\left( y-x\right) }{4\sqrt[p]{\vartheta p+1}} \left[ \left( \left| \sigma'\left( \nu_{1}\right) \right|^{q}+\left| \sigma'\left(\nu_{2}\right)\right| ^{q} -\left(\frac{\left|\sigma'(x) \right|^{q}+3\left|\sigma'(y)\right|^{q}}{4}\right)\right)^{\frac{1}{q}}\right. \\ \left. +\left( \left| \sigma'\left( \nu_{1}\right) \right|^{q}+\left|\sigma'\left(\nu_{2}\right)\right|^{q} -\left(\frac{3\left|\sigma'(x)\right|^{q}+\left|\sigma'(y)\right|^{q}}{4}\right)\right)^{\frac{1}{q}}\right], \end{multline}$

(2.10)

where $\frac{1}{p}+\frac{1}{q} = 1$ .

Proof. By taking modulus of identity (2.7) and using Hölder's inequality, we get

$\begin{multline*} \left| \frac{2^{\vartheta -1}\Gamma \left( \vartheta +1\right) }{\left(y-x\right)^{\vartheta }} \left[ J_{\left( \nu_{1}+\nu_{2}-y\right)+}^{\vartheta }\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right) \right. \right. \\ \left. \left. +\; J_{\left(\nu_{1}+\nu_{2}-x\right)-}^{\vartheta }\sigma\left(\nu_{1}+\nu_{2}-\frac{x+y}{2}\right) \right] -\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right) \right| \\ \leq \frac{\left( y-x\right) }{4}\left( \int_{0}^{1}\eta^{\vartheta p}\right)^{\frac{1}{p}} \left\{\left(\int_{0}^{1} \left|\sigma'\left(\nu_{1}+\nu_{2}-\left(\frac{1-\eta}{2}x+\frac{1+\eta}{2}y\right)\right)\right|^{q}d\eta\right) ^{\frac{1}{q}}\right. \\ \left. +\left(\int_{0}^{1} \left|\sigma'\left(\nu_{1}+\nu_{2}-\left(\frac{1+\eta}{2}x+\frac{1-\eta}{2}y\right)\right)\right|^{q}d\eta\right) ^{\frac{1}{q}}\right\}. \end{multline*}$

Then, by applying the Jensen-Mercer inequality with the convexity of $\left|\sigma'\right|^{q}$ , we can deduce

$\begin{align*} &\left| \frac{2^{\vartheta -1}\Gamma \left( \vartheta +1\right) }{\left(y-x\right) ^{\vartheta }} \left[J_{\left(\nu_{1}+\nu_{2}-y\right)+}^{\vartheta }\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right) \right. \right. \\ &\left. \left. +\; J_{\left( \nu_{1}+\nu_{2}-x\right) -}^{\vartheta }\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right) \right] -\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right) \right| \\ &\leq \frac{\left( y-x\right) }{4}\left( \int_{0}^{1}\eta^{\vartheta p}\right)^{\frac{1}{p}} \left\{ \left( \int_{0}^{1}\left| \sigma'\left( \nu_{1}\right)\right| ^{q}+\left| \sigma'\left( \nu_{2}\right) \right|^{q} -\left(\frac{1-\eta}{2}\left|\sigma'(x)\right|^{q}+\frac{1+\eta}{2}\left|\sigma'(y)\right|^{q}\right)\right)^{\frac{1}{q}}\right. \\ &\left. +\left( \int_{0}^{1}\left| \sigma'\left( \nu_{1}\right)\right| ^{q}+\left| \sigma'\left( \nu_{2}\right) \right|^{q} -\left(\frac{1+\eta}{2}\left| \sigma'\left( x\right)\right|^{q}+\frac{1-\eta}{2}\left| \sigma'\left( y\right) \right|^{q} \right) \right)^{\frac{1}{q}}\right\} \\ & = \frac{\left(y-x\right)}{4\sqrt[p]{\vartheta p+1}}\left[\left( \left| \sigma'\left( \nu_{1}\right) \right| ^{q} +\left|\sigma'\left( \nu_{2}\right) \right| ^{q}-\left( \frac{\left|\sigma'\left( x\right) \right|^{q} +3\left| \sigma'\left(y\right) \right|^{q} }{4}\right) \right) ^{\frac{1}{q}}\right. \\ &\left. +\left( \left| \sigma'\left( \nu_{1}\right) \right|^{q}+\left| \sigma'\left( \nu_{2}\right) \right| ^{q} -\left(\frac{3\left|\sigma'(x)\right|^{q}+\left|\sigma'(y)\right|^{q}}{4}\right)\right)^{\frac{1}{q}}\right], \end{align*}$

which completes the proof of Theorem 2.3.

Corollary 2.4. Theorem 2.3 with

● $\vartheta = 1$ becomes:

$\begin{multline*} \left|\frac{1}{y-x}\int_{\nu_{1}+\nu_{2}-y}^{\nu_{1}+\nu_{2}-x}\sigma\left(w\right)dw -\sigma\left(\nu_{1}+\nu_{2}-\frac{x+y}{2}\right)\right| \\ \leq \frac{\left( y-x\right)}{4\sqrt[p]{p+1}}\left[\left( \left| \sigma'\left( \nu_{1}\right) \right|^{q} +\left|\sigma'\left( \nu_{2}\right) \right| ^{q}-\left( \frac{\left|\sigma'\left( x\right) \right|^{q} +3\left|\sigma'\left(y\right) \right|^{q}}{4}\right)\right)^{\frac{1}{q}}\right. \\ \left. +\left(\left|\sigma'\left( \nu_{1}\right)\right|^{q}+\left| \sigma'\left( \nu_{2}\right)\right|^{q} -\left(\frac{3\left|\sigma'(x)\right|^{q}+\left|\sigma'(y)\right|^{q} }{4}\right)\right)^{\frac{1}{q}}\right]. \end{multline*}$

● $\vartheta = 1$ , $x = \nu_{1}$ and $y = \nu_{2}$ becomes:

$\begin{align*} &&\left\vert \frac{1}{\nu_{2}-\nu_{1}}\int_{\nu_{1}}^{\nu_{2}}\sigma\left( w\right) dw-\sigma\left(\frac{\nu_{1}+\nu_{2}}{2}\right) \right\vert \leq \frac{\left( \nu_{2}-\nu_{1}\right) }{2^{\frac{2}{p}}}\left(\frac{1}{p+1}\right)^{\frac{1}{p}}\left[ \left\vert \sigma^{\prime }\left( \nu_{1}\right) \right\vert +\left\vert \sigma^{\prime }\left( \nu_{2}\right) \right\vert \right] . \end{align*}$

● $x = \nu_{1}$ and $y = \nu_{2}$ becomes:

$\begin{align*} &\left\vert \frac{2^{\vartheta-1}\Gamma\left(\vartheta+1\right)}{\left(\nu_{2}-\nu_{1}\right)^{\vartheta}} \left[ J_{\nu_{1}+}^{\vartheta }\sigma\left(\frac{\nu_{1}+\nu_{2}}{2}\right) \right. \right. \left. \left. +\; J_{\nu_{2}-}^{\vartheta }\sigma\left(\frac{\nu_{1}+\nu_{2}}{2}\right) \right] -\sigma\left(\frac{\nu_{1}+\nu_{2}}{2}\right) \right\vert \\ &\leq \frac{2^{\vartheta-1-\frac{2}{q}}}{\nu_{2}-\nu_{1}}\left(\frac{1}{p+1}\right)^{\frac{1}{p}}\left[ \left\vert \sigma'\left( \nu_{1}\right) \right\vert +\left\vert \sigma'\left( \nu_{2}\right) \right\vert \right]. \end{align*}$

Theorem 2.4. Let $\sigma:[\nu_{1}, \nu_{2}]\subseteq\bf{R}\to\bf{R}$ be a differentiable function on $(\nu_{1}, \nu_{2})$ and $\left|\sigma'\right|^{q}, q\geq 1$ is convex on $[\nu_{1}, \nu_{2}]$ with $\nu_{1}\leq \nu_{2}$ and $x, y\in[\nu_{1}, \nu_{2}]$ . Then, we have:

$\begin{multline} \left| \frac{2^{\vartheta -1}\Gamma \left( \vartheta +1\right) }{\left(y-x\right) ^{\vartheta }} \left[ J_{\left( \nu_{1}+\nu_{2}-y\right) +}^{\vartheta }\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right)\right.\right. \\ \left. \left. +\; J_{\left( \nu_{1}+\nu_{2}-x\right) -}^{\vartheta }\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right) \right] -\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right) \right| \\ \leq \frac{\left(y-x\right)}{4\left(\vartheta+1\right)}\left[\left(\left|\sigma'(\nu_{1})\right|^{q} +\left|\sigma'\left(\nu_{2}\right)\right|^{q}-\left( \frac{\left| \sigma'\left(x\right)\right|^{q} +\left( 2\vartheta+3\right)\left|\sigma'(y)\right|^{q}}{2\left(\vartheta+2\right) }\right)\right)^{\frac{1}{q}}\right. \\ \left. +\left( \left|\sigma'\left(\nu_{1}\right)\right|^{q}+\left| \sigma'\left( \nu_{2}\right)\right|^{q} -\left(\frac{\left(2\vartheta+3\right)\left|\sigma'(x)\right|^{q}+\left|\sigma'(y)\right|^{q}}{2\left( \vartheta+2\right) }\right) \right) ^{\frac{1}{q}}\right]. \end{multline}$

(2.11)

Proof. By taking modulus of identity (2.7) with the well-known power mean inequality, we can deduce

$\begin{multline*} \left| \frac{2^{\vartheta -1}\Gamma \left( \vartheta +1\right) }{\left(y-x\right) ^{\vartheta }} \left[ J_{\left( \nu_{1}+\nu_{2}-y\right) +}^{\vartheta }\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right) \right. \right. \\ \left. \left. +\; J_{\left( \nu_{1}+\nu_{2}-x\right) -}^{\vartheta }\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right) \right] -\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right) \right| \\ \leq \frac{\left( y-x\right) }{4}\left( \int_{0}^{1}\eta^{\vartheta }\right) ^{1-\frac{1}{q}} \left\{\left(\int_{0}^{1}\eta^{\vartheta} \left|\sigma'\left(\nu_{1}+\nu_{2}-\left(\frac{1-\eta}{2}x+\frac{1+\eta}{2}y\right)\right)\right|^{q}d\eta\right)^{\frac{1}{q}}\right. \\ \left. +\left( \int_{0}^{1}\eta^{\vartheta } \left|\sigma'\left(\nu_{1}+\nu_{2}-\left(\frac{1+\eta}{2}x+\frac{1-\eta}{2}y\right)\right)\right|^{q}d\eta\right)^{\frac{1}{q}}\right\} . \end{multline*}$

By applying the Jensen-Mercer inequality with the convexity of $\left|\sigma'\right|^{q}$ , we can deduce

$\begin{align*} &\left| \frac{2^{\vartheta -1}\Gamma \left( \vartheta +1\right) }{\left(y-x\right)^{\vartheta}} \left[ J_{\left( \nu_{1}+\nu_{2}-y\right)+}^{\vartheta}\sigma\left(\nu_{1}+\nu_{2}-\frac{x+y}{2}\right) \right. \right. \\ &\left. \left. +\; J_{\left( \nu_{1}+\nu_{2}-x\right) -}^{\vartheta }\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right)\right] -\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right) \right| \\ &\leq \frac{\left( y-x\right)}{4}\left(\int_{0}^{1}\eta^{\vartheta }\right)^{1-\frac{1}{q}} \left\{ \left( \int_{0}^{1}\eta^{\vartheta }\left[ \left|\sigma'\left( \nu_{1}\right) \right|^{q} +\left| \sigma'\left(\nu_{2}\right) \right| ^{q}-\left( \frac{1-\eta}{2}\left| \sigma'\left(x\right)\right|^{q} +\frac{1+\eta}{2}\left| \sigma'\left( y\right)\right| ^{q}\right) \right] \right) ^{\frac{1}{q}}\right. \\ &\left. +\left( \int_{0}^{1}\eta^{\vartheta }\left[ \left| \sigma'\left(\nu_{1}\right)\right|^{q} +\left| \sigma'\left( \nu_{2}\right) \right|^{q}-\left( \frac{1+\eta}{2}\left| \sigma'\left( x\right) \right|^{q} +\frac{1-\eta}{2}\left| \sigma'\left( y\right) \right|^{q}\right) \right] \right) ^{\frac{1}{q}}\right\} \\ & = \frac{\left( y-x\right) }{4\left( \vartheta +1\right) }\left[\left(\left|\sigma'\left(\nu_{1}\right)\right|^{q} +\left|\sigma'\left( \nu_{2}\right) \right| ^{q}-\left( \frac{\left| \sigma'\left(x\right) \right|^{q} +\left(2\vartheta +3\right)\left|\sigma'(y)\right|^{q}}{2\left(\vartheta+2\right)}\right)\right)^{\frac{1}{q}}\right. \\ &\left. +\left( \left| \sigma'\left( \nu_{1}\right) \right|^{q}+\left|\sigma'\left( \nu_{2}\right)\right|^{q} -\left( \frac{\left( 2\vartheta +3\right) \left| \sigma'\left( x\right) \right|^{q} +\left|\sigma'\left( y\right)\right|^{q}}{2\left(\vartheta+2\right)}\right)\right)^{\frac{1}{q}}\right], \end{align*}$

which completes the proof of Theorem 2.4.

Corollary 5. Theorem 2.4 with

● $q = 1$ becomes Theorem 2.2.

● $\vartheta = 1$ becomes:

$\begin{multline*} \left| \frac{1}{y-x}\int_{\nu_{1}+\nu_{2}-y}^{\nu_{1}+\nu_{2}-x}\sigma\left(w\right) dw -\sigma\left( \nu_{1}+\nu_{2}-\frac{x+y}{2}\right) \right| \\ \leq \frac{\left( y-x\right) }{8}\left[ \left( \left|\sigma'\left( \nu_{1}\right)\right|^{q} +\left| \sigma'\left( \nu_{2}\right)\right|^{q}-\left( \frac{\left| \sigma'\left( x\right)\right|^{q} +5\left|\sigma'\left(y\right)\right|^{q}}{6}\right)\right)^{\frac{1}{q}}\right. \\ \left. +\left( \left| \sigma'\left( \nu_{1}\right) \right|^{q}+\left|\sigma'\left(\nu_{2}\right)\right|^{q} -\left(\frac{5\left|\sigma'(x)\right|^{q}+\left|\sigma'(y)\right|^{q}}{6}\right)\right)^{\frac{1}{q}}\right]. \end{multline*}$

● $\vartheta = 1$ , $x = \nu_{1}$ and $y = \nu_{2}$ becomes:

$\begin{multline*} \left| \frac{1}{\nu_{2}-\nu_{1}}\int_{\nu_{1}}^{\nu_{2}}\sigma\left( w\right) dw -\sigma\left(\frac{\nu_{1}+\nu_{2}}{2}\right)\right| \\ \leq \frac{\left(y-x\right)}{8}\left[\left(\frac{5\left|\sigma'\left(\nu_{1}\right)\right|^{q} +\left| \sigma'\left( \nu_{2}\right)\right| ^{q}}{6}\right)^{\frac{1}{q}} +\left(\frac{\left|\sigma'(\nu_{1})\right|^{q}+5\left| \sigma'(\nu_{2})\right|^{q}}{6}\right)^{\frac{1}{q}}\right]. \end{multline*}$

● $x = \nu_{1}$ and $y = \nu_{2}$ becomes:

$\begin{multline*} \left| \frac{2^{\vartheta-1}\Gamma\left(\vartheta+1\right)}{\left(\nu_{2}-\nu_{1}\right)^{\vartheta}} \left[J_{\nu_{1} +}^{\vartheta}\sigma\left(\frac{\nu_{1}+\nu_{2}}{2}\right)+\; J_{\nu_{2} -}^{\vartheta }\sigma\left( \frac{\nu_{1}+\nu_{2}}{2}\right)\right] -\sigma\left( \frac{\nu_{1}+\nu_{2}}{2}\right)\right| \\ \leq \frac{\left(\nu_{2}-\nu_{1}\right)}{4\left(\vartheta+1\right)} \left[\left(\frac{\left(2\vartheta+3\right)\left|\sigma'(\nu_{1})\right|^{q}+\left|\sigma'(\nu_{2})\right|^{q}}{2\left(\vartheta+2\right)}\right)^{\frac{1}{q}} +\left(\frac{\left|\sigma'(\nu_{1})\right|^{q}+\left(2\vartheta+3\right)\left|\sigma'(\nu_{2})\right|^{q}}{2\left(\vartheta+2\right)}\right) ^{\frac{1}{q}}\right]. \end{multline*}$

3. Applications to special means

Here, we consider the following special means:

● The arithmetic mean:

$\mathcal{A}(\nu_{1},\nu_{2}) = \frac{\nu_{1}+\nu_{2}}{2}, \quad \nu_{1}, \nu_{2}\geq 0.$

● The harmonic mean:

$\mathcal{H}(\nu_{1},\nu_{2}) = \frac{2\nu_{1}\nu_{2}}{\nu_{1}+\nu_{2}}, \quad \nu_{1}, \nu_{2} > 0.$

● The logarithmic mean:

$\begin{equation*} \mathcal{L}(\nu_{1},\nu_{2}) = \begin{cases} \frac{\nu_{2}-\nu_{1}}{\ln \nu_{2}-\ln \nu_{1}}, & \text{if}\; \nu_{1}\neq \nu_{2}, \\ \nu_{1}, & \text{if}\; \nu_{1} = \nu_{2}, \end{cases} \quad \nu_{1}, \nu_{2} > 0. \end{equation*}$

● The generalized logarithmic mean:

$\begin{equation*} \mathcal{L}_{n}(\nu_{1},\nu_{2}) = \begin{cases} \left[\frac{\nu_{2}^{n+1}-\nu_{1}^{n+1}}{\left(n+1\right)(\nu_{2}-\nu_{1})}\right]^{\frac{1}{n}}, & \text{if}\; \nu_{1}\neq \nu_{2} \\ \nu_{1}, & \text{if}\; \nu_{1} = \nu_{2}, \end{cases} \quad \nu_{1},\nu_{2} > 0;\; n\in\bf{Z}\setminus \{-1,0\}. \end{equation*}$

Proposition 3.1. Let $0 < \nu_{1} < \nu_{2}$ and $n\in\bf{N}$ , $n \geq 2$ . Then, for all $x, y\in[\nu_{1}, \nu_{2}]$ , we have:

(3.1)

Proof. By applying Corollary 2.3 (first item) for the convex function $\sigma(x) = x^{n}, \, x > 0$ , one can obtain the result directly.

Proposition 3.2. Let $0 < \nu_{1} < \nu_{2}$ . Then, for all $x, y\in[\nu_{1}, \nu_{2}]$ , we have:

(3.2)

Proof. By applying Corollary 2.3 (first item) for the convex function $\sigma(x) = \frac{1}{x}, \, x > 0$ , one can obtain the result directly.

Proposition 3.3. Let $0 < \nu_{1} < \nu_{2}$ and $n\in\bf{N}$ , $n \geq 2$ . Then, we have:

$\begin{equation} \left| \mathcal{L}_{n}^{n}(\nu_{1},\nu_{2}) -\mathcal{A}^{n}(\nu_{1},\nu_{2}) \right| \leq \frac{n(\nu_{2}-\nu_{1})}{4} \left[ \mathcal{A}\left(\nu_{1}^{n-1}, \nu_{2}^{n-1}\right) \right], \end{equation}$

(3.3)

and

$\begin{equation} \left| \mathcal{L}^{-1}(\nu_{1},\nu_{2}) -\mathcal{A}^{-1}(\nu_{1},\nu_{2}) \right| \leq \frac{(\nu_{2}-\nu_{1})}{4}\mathcal{H}^{-1}\left( \nu_{1}^{2},\nu_{2}^{2}\right) . \end{equation}$

(3.4)

Proof. By setting $x = \nu_{1}$ and $y = \nu_{2}$ in results of Proposition 3.1 and Proposition 3.2, one can obtain the Proposition 3.3.

Proposition 3.4. Let $0 < \nu_{1} < \nu_{2}$ and $n\in\bf{N}$ , $n \geq 2$ . Then, for $q > 1, \, \frac{1}{p}+\frac{1}{q} = 1$ and for all $x, y\in[\nu_{1}, \nu_{2}],$ we have:

$\begin{multline} \left| \mathcal{L}_{n}^{n}\left( \nu_{1}+\nu_{2}-y,\nu_{1}+\nu_{2}-x\right) -\left( 2\mathcal{A}(\nu_{1},\nu_{2}) -\mathcal{A}\left( x,y\right) \right) ^{n}\right| \\ \leq \frac{n(y-x)}{4\sqrt[p]{p+1}}\Bigg\{\left[ 2\mathcal{A}\left( \nu_{1}^{q(n-1)}, \nu_{2}^{q(n-1)}\right) -\frac{1}{2}\mathcal{A}\left(x^{q(n-1)}, 3y^{q(n-1)}\right) \right]^{\frac{1}{q}} \\ +\left[ 2\mathcal{A}\left( \nu_{1}^{q(n-1)}, \nu_{2}^{q(n-1)}\right) -\frac{1}{2}\mathcal{A}\left(3x^{q(n-1)}, y^{q(n-1)}\right) \right]^{\frac{1}{q}}\Bigg\}. \end{multline}$

(3.5)

Proof. By applying Corollary 2.4 (first item) for convex function $\sigma\left(x\right) = x^{n}, \, x > 0$ , one can obtain the result directly.

Proposition 3.5. Let $0 < \nu_{1} < \nu_{2}$ . Then, for $q > 1, \, \frac{1}{p}+\frac{1}{q} = 1$ and for all $x, y\in[\nu_{1}, \nu_{2}]$ , we have:

$\begin{multline} \left| \mathcal{L}^{-1}\left( \nu_{1}+\nu_{2}-y,\nu_{1}+\nu_{2}-x\right) -\left( 2\mathcal{A}(\nu_{1},\nu_{2}) -\mathcal{A}\left(x,y\right)\right)^{-1}\right| \\ \leq \frac{\sqrt[q]{2}(y-x)}{4\sqrt[p]{p+1}}\Bigg\{\left[ \mathcal{H}^{-1}\left(\nu_{1}^{2q},\nu_{2}^{2q}\right) -\frac{3}{4}\mathcal{H}^{-1}\left(x^{2q}, 3y^{2q}\right) \right]^{\frac{1}{q}} \\ +\left[\mathcal{H}^{-1}\left(\nu_{1}^{2q},\nu_{2}^{2q}\right) -\frac{3}{4}\mathcal{H}^{-1}\left(3x^{2q}, y^{2q}\right) \right]^{\frac{1}{q}}\Bigg\}. \end{multline}$

(3.6)

Proof. By applying Corollary 2.4 (first item) for the convex function $\sigma\left(x\right) = \frac{1}{x}, \, x > 0$ , one can obtain the result directly.

Proposition 3.6. Let $0 < \nu_{1} < \nu_{2}$ and $n\in\bf{N}$ , $n \geq 2$ . Then, for $q > 1$ and $\frac{1}{p}+\frac{1}{q} = 1$ , we have:

$\begin{multline} \left| \mathcal{L}_{n}^{n}(\nu_{1},\nu_{2}) -\mathcal{A}^{n}(\nu_{1},\nu_{2}) \right| \leq \frac{n(\nu_{2}-\nu_{1})}{4\sqrt[p]{p+1}} \Bigg\{\left[ 2\mathcal{A}\left( \nu_{1}^{q(n-1)}, \nu_{2}^{q(n-1)}\right) -\frac{1}{2}\mathcal{A}\left( \nu_{1}^{q(n-1)}, 3\nu_{2}^{q(n-1)}\right) \right]^{\frac{1}{q}} \\ +\left[ 2\mathcal{A}\left( \nu_{1}^{q(n-1)}, \nu_{2}^{q(n-1)}\right) -\frac{1}{2}\mathcal{A}\left(3\nu_{1}^{q(n-1)}, \nu_{2}^{q(n-1)}\right) \right]^{\frac{1}{q}}\Bigg\}, \end{multline}$

(3.7)

and

$\begin{multline} \left| \mathcal{L}^{-1}(\nu_{1},\nu_{2}) -\mathcal{A}^{-1}(\nu_{1},\nu_{2}) \right| \leq \frac{\sqrt[q]{2}(\nu_{2}-\nu_{1})}{4\sqrt[p]{p+1}} \Bigg\{\left[ \mathcal{H}^{-1}\left( \nu_{1}^{2q}, \nu_{2}^{2q}\right) -\frac{3}{4}\mathcal{H}^{-1}\left(\nu_{1}^{2q}, 3\nu_{2}^{2q}\right) \right]^{\frac{1}{q}} \\ +\left[ \mathcal{H}^{-1}\left( \nu_{1}^{2q}, \nu_{2}^{2q}\right) -\frac{3}{4}\mathcal{H}^{-1}\left(3\nu_{1}^{2q}, \nu_{2}^{2q}\right) \right]^{\frac{1}{q}}\Bigg\}. \end{multline}$

(3.8)

Proof. By setting $x = \nu_{1}$ and $y = \nu_{2}$ in results of Proposition 3.4 and Proposition 3.5, one can obtain the Proposition 3.6.

4. Conclusions

As we emphasized in the introduction, integral inequality is the most important field of mathematical analysis and fractional calculus. By using the well-known Jensen-Mercer and power mean inequalities, we have proved new inequalities of Hermite-Hadamard-Mercer type involving Riemann-Liouville fractional operators. In the last section, we have considered some propositions in the context of special functions; these confirm the efficiency of our results.

Acknowledgements

We would like to express our special thanks to the editor and referees. Also, the first author would like to thank Prince Sultan University for funding this work through research group Nonlinear Analysis Methods in Applied Mathematics (NAMAM) group number RG-DES-2017-01-17.

Conflict of interest

The authors declare no conflict of interest.

Authors' contributions

All authors participated in the conception and writing of this manuscript.

Conflict of interest

All authors have no conflicts of interest.

References

[1]	Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA: Cancer J Clin 68: 7-30. https://doi.org/10.3322/caac.21442
[2]	dela Cruz CS, Tanoue LT, Matthay RA (2011) Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med 32: 605-644. https://doi.org/10.1016/j.ccm.2011.09.001
[3]	de Groot PM, Wu CC, Carter BW, et al. (2018) The epidemiology of lung cancer. Transl Lung Cancer Res 7: 220-233. https://doi.org/10.21037/tlcr.2018.05.06
[4]	Torre LA, Siegel RL, Jemal A (2016) Lung cancer statistics. Adv Exp Med Biol 893: 1-19. https://doi.org/10.1007/978-3-319-24223-1_1
[5]	North CM, Christiani DC (2013) Women and lung cancer: what is new?. Semin Thorac Cardiovasc Surg 25: 87-94. https://doi.org/10.1053/j.semtcvs.2013.05.002
[6]	Pelosof L, Ahn C, Gao A, et al. (2017) Proportion of never-smoker non-small cell lung cancer patients at three diverse institutions. J Natl Cancer Inst 109: djw295. https://doi.org/10.1093/jnci/djw295
[7]	Howlader N, Forjaz G, Mooradian MJ, et al. (2020) The effect of advances in lung-cancer treatment on population mortality. N Engl J Med 383: 640-649. https://doi.org/10.1056/NEJMoa1916623
[8]	Travis WD, Brambilla E, Nicholson AG, et al. (2015) The 2015 World Health Organization Classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol 10: 1243-1260. https://doi.org/10.1097/JTO.0000000000000630
[9]	Takamochi K, Ohmiya H, Itoh M, et al. (2016) Novel biomarkers that assist in accurate discrimination of squamous cell carcinoma from adenocarcinoma of the lung. BMC Cancer 16: 760. https://doi.org/10.1186/s12885-016-2792-1
[10]	Goldstraw P, Chansky K, Crowley J, et al. (2016) The IASLC Lung Cancer Staging Project: proposals for revision of the TNM Stage Groupings in the Forthcoming (Eighth) edition of the TNM classification for lung cancer. J Thorac Oncol 11: 39-51. https://doi.org/10.1016/j.jtho.2015.09.009
[11]	Doria-Rose VP, Szabo E (2010) Screening and prevention of lung cancer. Lung Cancer: A Multidisciplinary Approach to Diagnosis and Management . New York: Demos Medical Publishing 53-72.
[12]	Oken MM, Hocking WG, Kvale PA, et al. (2011) Screening by chest radiograph and lung cancer mortality: the prostate, lung, colorectal, and ovarian (PLCO) randomized trial. JAMA 306: 1865-1873. https://doi.org/10.1001/jama.2011.1591
[13]	Aberle DR, Adams AM, et al. (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365: 395-409. https://doi.org/10.1056/NEJMoa1102873
[14]	Moyer VA (2014) Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Int Med 160: 330-338. https://doi.org/10.7326/M13-2771
[15]	de Koning HJ, van der Aalst CM, de Jong PA, et al. (2020) Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med 382: 503-513. https://doi.org/10.1056/NEJMoa1911793
[16]	Krist AH, Davidson KW, et al. (2021) Screening for lung cancer: US Preventive Services Task Force Recommendation Statement. JAMA 325: 962-970. https://doi.org/10.1001/jama.2021.1117
[17]	Meza R, Jeon J, Toumazis I, et al. (2021) Evaluation of the benefits and harms of lung cancer screening with low-dose computed tomography: a collaborative modeling study for the U.S. Preventive Services Task Force. Agency for Healthcare Research and Quality . Report No.: 20th-05266-EF-2nd ed
[18]	Toumazis I, Bastani M, Han SS, et al. (2020) Risk-based lung cancer screening: a systematic review. Lung Cancer 147: 154-186. https://doi.org/10.1016/j.lungcan.2020.07.007
[19]	Shim J, Brindle L, Simon M, et al. (2014) A systematic review of symptomatic diagnosis of lung cancer. Fam Pract 31: 137-148. https://doi.org/10.1093/fampra/cmt076
[20]	Silvestri GA, Gonzalez AV, Jantz MA, et al. (2013) Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143: e211S-e250S. https://doi.org/10.1378/chest.12-2355
[21]	Purandare NC, Rangarajan V (2015) Imaging of lung cancer: implications on staging and management. Indian J Radiol Imaging 25: 109-120. https://doi.org/10.4103/0971-3026.155831
[22]	Lababede O, Meziane MA (2018) The Eighth Edition of TNM staging of lung cancer: reference chart and diagrams. Oncologist 23: 844-848. https://doi.org/10.1634/theoncologist.2017-0659
[23]	Dorry M, Davidson K, Dash R, et al. (2021) Pleural effusions associated with squamous cell lung carcinoma have a low diagnostic yield and a poor prognosis. Transl Lung Cancer Res 10: 2500-2508. https://doi.org/10.21037/tlcr-21-123
[24]	Figueiredo VR, Cardoso PFG, Jacomelli M, et al. (2020) EBUS-TBNA versus surgical mediastinoscopy for mediastinal lymph node staging in potentially operable non-small cell lung cancer: a systematic review and meta-analysis. J Bras Pneumol 46: e20190221. https://doi.org/10.36416/1806-3756/e20190221
[25]	Sehgal IS, Agarwal R, Dhooria S, et al. (2019) Role of EBUS TBNA in staging of lung cancer: a clinician's perspective. J Cytol 36: 61-64. https://doi.org/10.4103/JOC.JOC_172_18
[26]	Schimmer C, Neukam K, Elert O (2006) Staging of non-small cell lung cancer: clinical value of positron emission tomography and mediastinoscopy. Interact Cardiovasc Thorac Surg 5: 418-423. https://doi.org/10.1510/icvts.2006.129478
[27]	Schmidt-Hansen M, Baldwin DR, Hasler E, et al. (2014) PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer. Cochrane Database Syst Rev 2014: CD009519. https://doi.org/10.1002/14651858.CD009519.pub2
[28]	de Leyn P, Dooms C, Kuzdzal J, et al. (2014) Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg 45: 787-798. https://doi.org/10.1093/ejcts/ezu028
[29]	Rivera MP, Mehta AC, Wahidi MM (2013) Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143: e142S-e165S. https://doi.org/10.1378/chest.12-2353
[30]	Leighl NB, Page RD, Raymond VM, et al. (2019) Clinical utility of comprehensive cell-free DNA analysis to identify genomic biomarkers in patients with newly diagnosed metastatic non-small cell lung cancer. Clin Cancer Res 25: 4691-4700. https://doi.org/10.1158/1078-0432.CCR-19-0624
[31]	Guardant Health Guardant360® CDx First FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-first-liquid-biopsy-next-generation-sequencing-companion-diagnostic-test
[32]	Ferreira D, Miranda J, Martins-Lopes P, et al. (2021) Future perspectives in detecting EGFR and ALK gene alterations in liquid biopsies of patients with NSCLC. Int J Mol Sci 22: 3815. https://doi.org/10.3390/ijms22083815
[33]	Papadimitrakopoulou VA, Han JY, Ahn MJ, et al. (2020) Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum-pemetrexed for T790M mutation-positive advanced non-small cell lung cancer. Cancer 126: 373-380. https://doi.org/10.1002/cncr.32503
[34]	FoundationOne CDxTM Technical Information. Available from: https://www.foundationmedicine.com/test/foundationone-cdx
[35]	Hartmaier R, Han JY, Ahn MJ, et al. (2020) Abstract CT303: The effect of savolitinib plus osimertinib on ctDNA clearance in patients with EGFR mutation positive (EGFRm) MET -amplified NSCLC in the TATTON study. Bioinformatics, Convergence Science, and Systems Biology. AACR 80: CT303. https://doi.org/10.1158/1538-7445.AM2020-CT303
[36]	le Pechoux C, Pourel N, Barlesi F, et al. (2022) Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial. Lancet Oncol 23: 104-114. https://doi.org/10.1016/S1470-2045(21)00606-9
[37]	Hui Z, Men Y, Hu C, et al. (2021) Effect of postoperative radiotherapy for patients with pIIIA-N2 non-small cell lung cancer after complete resection and adjuvant chemotherapy: the phase 3 PORT-C randomized clinical trial. JAMA Oncol 7: 1178-1185. https://doi.org/10.1001/jamaoncol.2021.1910
[38]	Detterbeck FC, Lewis SZ, Diekemper R, et al. (2013) Executive summary: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143: 7S-37S. https://doi.org/10.1378/chest.12-2377
[39]	Ginsberg RJ, Rubinstein LV (1995) Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 60: 615-622; discussion 622-3. https://doi.org/10.1016/0003-4975(95)00537-u
[40]	Howington JA, Blum MG, Chang AC, et al. (2013) Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143: e278S-e313S. https://doi.org/10.1378/chest.12-2359
[41]	Mery CM, Pappas AN, Bueno R, et al. (2005) Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest 128: 237-245. https://doi.org/10.1378/chest.128.1.237
[42]	Veluswamy RR, Ezer N, Mhango G, et al. (2015) Limited resection versus lobectomy for older patients with early-stage lung cancer: impact of histology. J Clin Oncol 33: 3447-3453. https://doi.org/10.1200/JCO.2014.60.6624
[43]	Saji H, Okada M, Tsuboi M, et al. (2022) Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet 399: 1607-1617. https://doi.org/10.1016/S0140-6736(21)02333-3
[44]	Lardinois D, de Leyn P, van Schil P, et al. (2006) ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg 30: 787-792. https://doi.org/10.1016/j.ejcts.2006.08.008
[45]	FDA approves atezolizumab as adjuvant treatment for non-small cell lung cancer. Available from: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-atezolizumab-adjuvant-treatment-non-small-cell-lung-cancer
[46]	Ball D, Mai GT, Vinod S, et al. (2019) Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial. Lancet Oncol 20: 494-503. https://doi.org/10.1016/S1470-2045(18)30896-9
[47]	Nyman J, Hallqvist A, Lund JÅ, et al. (2016) SPACE—A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC. Radiother Oncol 121: 1-8. https://doi.org/10.1016/j.radonc.2016.08.015
[48]	Francis S, Orton A, Stoddard G, et al. (2018) Sequencing of postoperative radiotherapy and chemotherapy for locally advanced or incompletely resected non-small-cell lung cancer. J Clin Oncol 36: 333-341. https://doi.org/10.1200/JCO.2017.74.4771
[49]	O'Rourke N, I Figuls MR, Bernadó NF, et al. (2010) Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database Syst Rev CD002140. https://doi.org/10.1002/14651858.CD002140.pub3
[50]	Spigel DR, Faivre-Finn C, Gray JE, et al. (2022) Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. J Clin Oncol 40: 1301-1311. https://doi.org/10.1200/JCO.21.01308
[51]	Jabbour SK, Lee KH, Frost N, et al. (2021) Pembrolizumab plus concurrent chemoradiation therapy in patients with unresectable, locally advanced, stage III non-small cell lung cancer: the phase 2 KEYNOTE-799 nonrandomized trial. JAMA Oncol 7: 1-9. https://doi.org/10.1001/jamaoncol.2021.2301
[52]	Reck M, Rodríguez-Abreu D, Robinson AG, et al. (2016) Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med 375: 1823-1833. https://doi.org/10.1056/NEJMoa1606774
[53]	Ettinger DS, Wood DE, Aisner DL, et al. (2022) Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 20: 497-530. https://doi.org/10.6004/jnccn.2022.0025
[54]	Jasper K, Stiles B, McDonald F, et al. (2022) Practical management of oligometastatic non-small-cell lung cancer. J Clin Oncol 40: 635-641. https://doi.org/10.1200/JCO.21.01719
[55]	Soria JC, Ohe Y, Vansteenkiste J, et al. (2018) Osimertinib in untreated EGFR-Mutated advanced non-small-cell lung cancer. N Engl J Med 378: 113-125. https://doi.org/10.1056/NEJMoa1713137
[56]	Friedlaender A, Banna G, Patel S, et al. (2019) Diagnosis and treatment of ALK aberrations in metastatic NSCLC. Curr Treat Options Oncol 20: 79. https://doi.org/10.1007/s11864-019-0675-9
[57]	FDA approves first therapy for patients with lung and thyroid cancers with a certain genetic mutation or fusion. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-first-therapy-patients-lung-and-thyroid-cancers-certain-genetic-mutation-or-fusion
[58]	FDA approves entrectinib for NTRK solid tumors and ROS-1 NSCLC. Available from: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-entrectinib-ntrk-solid-tumors-and-ros-1-nsclc
[59]	Wang EH, Corso CD, Rutter CE, et al. (2015) Postoperative Radiation therapy is associated with improved overall survival in incompletely resected stage II and III non-small-cell lung cancer. J Clin Oncol 33: 2727-2734. https://doi.org/10.1200/JCO.2015.61.1517
[60]	Foundation Medicine's ctDNA Monitoring Assay, FoundationOne®Tracker, Granted Breakthrough Device Designation by U.S. Food and Drug Administration. Available from: https://www.fdanews.com/articles/206649-foundation-medicines-foundationone-cancer-tracker-named-breakthrough-device

This article has been cited by:

1.	Tariq A. Aljaaidi, Deepak B. Pachpatte, Ram N. Mohapatra, The Hermite–Hadamard–Mercer Type Inequalities via Generalized Proportional Fractional Integral Concerning Another Function, 2022, 2022, 1687-0425, 1, 10.1155/2022/6716830
2.	Saad Ihsan Butt, Ahmet Ocak Akdemir, Muhammad Nadeem, Nabil Mlaiki, İşcan İmdat, Thabet Abdeljawad, $(m, n)$ -Harmonically polynomial convex functions and some Hadamard type inequalities on the co-ordinates, 2021, 6, 2473-6988, 4677, 10.3934/math.2021275
3.	Ifra Bashir Sial, Nichaphat Patanarapeelert, Muhammad Aamir Ali, Hüseyin Budak, Thanin Sitthiwirattham, On Some New Ostrowski–Mercer-Type Inequalities for Differentiable Functions, 2022, 11, 2075-1680, 132, 10.3390/axioms11030132
4.	Deniz Uçar, Inequalities for different type of functions via Caputo fractional derivative, 2022, 7, 2473-6988, 12815, 10.3934/math.2022709
5.	Soubhagya Kumar Sahoo, Y.S. Hamed, Pshtiwan Othman Mohammed, Bibhakar Kodamasingh, Kamsing Nonlaopon, New midpoint type Hermite-Hadamard-Mercer inequalities pertaining to Caputo-Fabrizio fractional operators, 2023, 65, 11100168, 689, 10.1016/j.aej.2022.10.019
6.	Muhammad Imran Asjad, Waqas Ali Faridi, Mohammed M. Al-Shomrani, Abdullahi Yusuf, The generalization of Hermite-Hadamard type Inequality with exp-convexity involving non-singular fractional operator, 2022, 7, 2473-6988, 7040, 10.3934/math.2022392
7.	Churong Chen, Discrete Caputo Delta Fractional Economic Cobweb Models, 2023, 22, 1575-5460, 10.1007/s12346-022-00708-5
8.	Soubhagya Kumar Sahoo, Ravi P. Agarwal, Pshtiwan Othman Mohammed, Bibhakar Kodamasingh, Kamsing Nonlaopon, Khadijah M. Abualnaja, Hadamard–Mercer, Dragomir–Agarwal–Mercer, and Pachpatte–Mercer Type Fractional Inclusions for Convex Functions with an Exponential Kernel and Their Applications, 2022, 14, 2073-8994, 836, 10.3390/sym14040836
9.	Muhammad Tariq, Sotiris K. Ntouyas, Asif Ali Shaikh, A Comprehensive Review of the Hermite–Hadamard Inequality Pertaining to Fractional Integral Operators, 2023, 11, 2227-7390, 1953, 10.3390/math11081953
10.	Loredana Ciurdariu, Eugenia Grecu, Hermite–Hadamard–Mercer-Type Inequalities for Three-Times Differentiable Functions, 2024, 13, 2075-1680, 413, 10.3390/axioms13060413
11.	Muhammad Aamir Ali, Thanin Sitthiwirattham, Elisabeth Köbis, Asma Hanif, Hermite–Hadamard–Mercer Inequalities Associated with Twice-Differentiable Functions with Applications, 2024, 13, 2075-1680, 114, 10.3390/axioms13020114
12.	Muhammad Aamir Ali, Christopher S. Goodrich, On some new inequalities of Hermite–Hadamard–Mercer midpoint and trapezoidal type in q-calculus, 2024, 44, 0174-4747, 35, 10.1515/anly-2023-0019
13.	Thanin Sitthiwirattham, Ifra Sial, Muhammad Ali, Hüseyin Budak, Jiraporn Reunsumrit, A new variant of Jensen inclusion and Hermite-Hadamard type inclusions for interval-valued functions, 2023, 37, 0354-5180, 5553, 10.2298/FIL2317553S
14.	Muhammad Aamir Ali, Zhiyue Zhang, Michal Fečkan, GENERALIZATION OF HERMITE–HADAMARD–MERCER AND TRAPEZOID FORMULA TYPE INEQUALITIES INVOLVING THE BETA FUNCTION, 2024, 54, 0035-7596, 10.1216/rmj.2024.54.331
15.	Bahtiyar Bayraktar, Péter Kórus, Juan Eduardo Nápoles Valdés, Some New Jensen–Mercer Type Integral Inequalities via Fractional Operators, 2023, 12, 2075-1680, 517, 10.3390/axioms12060517
16.	THANIN SITTHIWIRATTHAM, MIGUEL VIVAS-CORTEZ, MUHAMMAD AAMIR ALI, HÜSEYIN BUDAK, İBRAHIM AVCI, A STUDY OF FRACTIONAL HERMITE–HADAMARD–MERCER INEQUALITIES FOR DIFFERENTIABLE FUNCTIONS, 2024, 32, 0218-348X, 10.1142/S0218348X24400164
17.	Muhammad Ali, Hüseyin Budak, Elisabeth Köbis, Some new and general versions of q-Hermite-Hadamard-Mercer inequalities, 2023, 37, 0354-5180, 4531, 10.2298/FIL2314531A
18.	Ebru Yüksel, On Ostrowski-Mercer type inequalities for twice differentiable convex functions, 2024, 38, 0354-5180, 6945, 10.2298/FIL2419945Y
19.	Muhammad Ali, Hüseyin Budak, Michal Feckan, Nichaphat Patanarapeelert, Thanin Sitthiwirattham, On some Newton’s type inequalities for differentiable convex functions via Riemann-Liouville fractional integrals, 2023, 37, 0354-5180, 3427, 10.2298/FIL2311427A

Reader Comments

Your name:*

Email:*
© 2022 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

AIMS Medical Science

0.4

Metrics

Article views(5787) PDF downloads(385) Cited by(7)

Preview PDF

Download XML

Export Citation

Article outline

Show full outline

Figures and Tables

Figures(1) / Tables(1)

AIMS Medical Science

Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment

Related Papers:

Abstract

1. Introduction

2. Main results

3. Applications to special means

4. Conclusions

Acknowledgements

Conflict of interest

References

This article has been cited by:

Reader Comments

通讯作者: 陈斌, bchen63@163.com

Metrics

Figures and Tables

Other Articles By Authors

Catalog

AIMS Medical Science

Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment

Related Papers:

Abstract

1. Introduction

2. Main results

3. Applications to special means

4. Conclusions

Acknowledgements

Conflict of interest

References

This article has been cited by:

Reader Comments

通讯作者: 陈斌, bchen63@163.com

Metrics

Figures and Tables

Other Articles By Authors

Related pages

Tools

Export File

Citation

Format

Content

Catalog